Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 19, Number 6—June 2013


BSE-associated Prion-Amyloid Cardiomyopathy in Primates

Susanne Krasemann, Giulia Mearini, Elisabeth Krämer, Katja Wagenführ, Walter Schulz-Schaeffer, Melanie Neumann, Walter Bodemer, Franz-Josef Kaup, Michael Beekes, Lucie Carrier, Adriano Aguzzi1, and Markus Glatzel1Comments to Author 
Author affiliations: University Medical Center Hamburg-Eppendorf, Hamburg, Germany (S. Krasemann, G. Mearini, E. Krämer, M. Neumann, L. Carrier, M. Glatzel); Robert Koch Institute, Berlin, Germany (K. Wagenführ, M. Beekes); University Hospital Göttingen, Göttingen, Germany (W. Schulz-Schaeffer); German Primate Center, Göttingen (W. Bodemer, F.-J. Kaup); University of Zurich, Zurich, Switzerland (A. Aguzzi)

Main Article


Characteristics of 3 rhesus macaques in study of BSE-associated prion-amyloid cardiomyopathy*

Primate Age at inoculation Time to clinical disease, mo Disease duration, wk Cardiac PrPSc Signs of cardiac distress at autopsy
BSE inoculated 8 y 49 4 Neg Neg
5 y 59 18 Pos Pos
1 y 61 4 Neg Neg
Control 8 mo NA NA Neg Neg
17 y NA NA Neg Neg
19 y NA NA Neg Neg

*BSE, bovine spongiform encephalopathy; Neg, negative; Pos, positive; NA, not applicable.

Main Article

1These authors contributed equally to this article.

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO